Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2014/03/24 00:17:50」(JST)

wiki en

Cardiobacterium hominis is a Gram-negative rod commonly grouped with other bacteria into the HACEK group. It is one of several bacteria normally present in the respiratory tract. However, it may also rarely cause endocarditis, an infection of the heart valves.^[1]

Microbiology[edit]

C. hominis is a catalase-negative, oxidase-positive, indole-producing Gram-negative rod.^[2] Its morphology has classically been described as highly pleomorphic and irregularly staining, although homogeneous bacilli with uniform shapes may be seen with the addition of yeast extract.^[2]

Antibiotic sensitivity[edit]

Historically C. hominis has been sensitive to penicillin and penicillin derivatives such as ampicillin.^[3] However, penicillin-resistant strains, including those that produce beta-lactamases, have been described with increasing frequency.^[4] Clinical guidelines thus recommend that C. hominis and other HACEK organisms be presumed to harbor ampicillin resistance and therefore be treated with a third-generation cephalosporin.^[3] C. hominis and other HACEK organisms also exhibit in vitro susceptibility to trimethoprim-sulfamethoxazole, fluoroquinolones, and aztreonam.^[3] C. hominis is often resistant to erythromycin.^[5]

References[edit]

^ Malani AN, Aronoff DM, Bradley SF, Kauffman CA (September 2006). "Cardiobacterium hominis endocarditis: Two cases and a review of the literature". European Journal of Clinical Microbiology & Infectious Diseases 25 (9): 587–95. doi:10.1007/s10096-006-0189-9. PMC 2276845. PMID 16955250. Retrieved 2010-03-15.
^ ^a ^b Savage DD, Kagan RL, Young NA, Horvath AE (January 1977). "Cardiobacterium hominis endocarditis: description of two patients and characterization of the organism". Journal of Clinical Microbiology 5 (1): 75–80. PMC 274535. PMID 833269. Retrieved 2010-03-15.
^ ^a ^b ^c Wilson WR, Karchmer AW, Dajani AS, et al. (December 1995). "Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association". JAMA 274 (21): 1706–13. doi:10.1001/jama.274.21.1706. PMID 7474277. |accessdate= requires |url= (help)
^ Lu PL, Hsueh PR, Hung CC, Teng LJ, Jang TN, Luh KT (May 2000). "Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis". Journal of Clinical Microbiology 38 (5): 2015–7. PMC 86656. PMID 10790145. Retrieved 2010-03-15.
^ Michael A. Pfaller; Murray, Patrick R.; Rosenthal, Ken S. (2009). Medical microbiology. Philadelphia: Mosby / Elsevier. p. 374. ISBN 0-323-05470-6.

External links[edit]

Image: Cardibacterium hominins

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 固有弁心内膜炎の抗菌療法 antimicrobial therapy of native valve endocarditis
2. 培養陰性感染性心内膜炎 culture negative endocarditis
3. 人工弁心内膜炎における抗菌療法 antimicrobial therapy of prosthetic valve endocarditis
4. 歯性感染症の疫学、病因、および臨床症状 epidemiology pathogenesis and clinical manifestations of odontogenic infections
5. 感染性心内膜炎の診断法 diagnostic approach to infective endocarditis

English Journal

Cardiobacterium hominis -induced acute dacryocystitis and lacrimal abscess.

Manderwad GP, Kodiganti M, Ali MJ.SourceDepartment of Ophthalmic Plastics, Kallam Anji Reddy Campus, L.V Prasad Eye Institute, Banjara Hills, Hyderabad, Andhra Pradesh, India.
Indian journal of ophthalmology.Indian J Ophthalmol.2013 Sep 6. [Epub ahead of print]
Cardiobacterium hominis is a member of the HACEK (Haemophilus sp., Actinobacillus actinomycetemcomitans, C. hominis, Eikenella corrodens, and Kingella kingae) group commonly associated with endocarditits and is normally present in the respiratory tract. We describe the first case of acute dacryocyst
PMID 24008805

Accurate identification of fastidious Gram-negative rods: integration of both conventional phenotypic methods and 16S rRNA gene analysis.

de Melo Oliveira MG, Abels S, Zbinden R, Bloemberg GV, Zbinden A.SourceInstitute of Medical Microbiology, University of Zurich, 8006 Zurich, Switzerland.
BMC microbiology.BMC Microbiol.2013 Jul 16;13:162. doi: 10.1186/1471-2180-13-162.
BACKGROUND: Accurate identification of fastidious Gram-negative rods (GNR) by conventional phenotypic characteristics is a challenge for diagnostic microbiology. The aim of this study was to evaluate the use of molecular methods, e.g., 16S rRNA gene sequence analysis for identification of fastidious
PMID 23855986

HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort.

Chambers ST, Murdoch D, Morris A, Holland D, Pappas P, Almela M, Fernández-Hidalgo N, Almirante B, Bouza E, Forno D, del Rio A, Hannan MM, Harkness J, Kanafani ZA, Lalani T, Lang S, Raymond N, Read K, Vinogradova T, Woods CW, Wray D, Corey GR, Chu VH; International Collaboration on Endocarditis Prospective Cohort Study Investigators.Collaborators (323)Clara L, Sanchez M, Nacinovich F, Oses P, Ronderos R, Sucari A, Thierer J, Casabé J, Cortes C, Altclas J, Sanatorio, Kogan S, Spelman D, Athan E, Harris O, Kennedy K, Tan R, Gordon D, Papanicolas L, Eisen D, Grigg L, Street A, Korman T, Kotsanas D, Dever R, Jones P, Konecny P, Lawrence R, Rees D, Ryan S, Feneley MP, Harkness J, Jones P, Ryan S, Jones P, Ryan S, Jones P, Post J, Reinbott P, Ryan S, Gattringer R, Wiesbauer F, Andrade AR, de Brito AC, Guimarães AC, Grinberg M, Mansur AJ, Siciliano RF, Strabelli TM, Vieira ML, de Medeiros Tranchesi RA, Paiva MG, Fortes CQ, Ramos Ade O, Ferraiuoli G, Golebiovski W, Lamas C, Santos M, Weksler C, Karlowsky JA, Keynan Y, Morris AM, Rubinstein E, Jones SB, Garcia P, Cereceda M, Fica A, Mella RM, Barsic B, Bukovski S, Krajinovic V, Pangercic A, Rudez I, Vincelj J, Freiberger T, Pol J, Zaloudikova B, Ashour Z, El Kholy A, Mishaal M, Rizk H, Aissa N, Alauzet C, Alla F, Campagnac C, Doco-Lecompte T, Selton-Suty C, Casalta JP, Fournier PE, Habib G, Raoult D, Thuny F, Delahaye F, Delahaye A, Vandenesch F, Donal E, Donnio PY, Michelet C, Revest M, Tattevin P, Violette J, Chevalier F, Jeu A, Rusinaru D, Sorel C, Tribouilloy C, Bernard Y, Chirouze C, Hoen B, Leroy J, Plesiat P, Naber C, Neuerburg C, Mazaheri B, Naber C, Neuerburg C, Athanasia S, Giannitsioti E, Mylona E, Paniara O, Papanicolaou K, Pyros J, Skoutelis A, Sharma G, Francis J, Nair L, Thomas DM, Venugopal K, Hannan M, Hurley J, Gilon D, Israel S, Korem M, Strahilevitz J, Rubinstein E, Strahilevitz J, Tripodi MF, Casillo R, Cuccurullo S, Dialetto G, Durante-Mangoni E, Irene M, Ragone E, Utili R, Cecchi E, De Rosa F, Forno D, Imazio M, Trinchero R, Tebini A, Grossi P, Lattanzio M, Toniolo A, Goglio A, Raglio A, Ravasio V, Rizzi M, Suter F, Carosi G, Magri S, Signorini L, Baban T, Kanafani Z, Kanj SS, Sfeir J, Yasmine M, Abidin I, Tamin SS, Martínez ER, Nieto GI, Chávez I, van der Meer JT, Chambers S, Holland D, Morris A, Raymond N, Read K, Murdoch DR, Dragulescu S, Ionac A, Mornos C, Butkevich OM, Chipigina N, Kirill O, Vadim K, Vinogradova T, Edathodu J, Halim M, Lum LN, Tan RS, Lejko-Zupanc T, Logar M, Mueller-Premru M, Commerford P, Commerford A, Deetlefs E, Hansa C, Ntsekhe M, Almela M, Armero Y, Azqueta M, Castañeda X, Cervera C, del Rio A, Falces C, Garcia-de-la-Maria C, Fita G, Gatell JM, Marco F, Mestres CA, Miró JM, Moreno A, Ninot S, Paré C, Pericas J, Ramirez J, Rovira I, Sitges M, Anguera I, Font B, Guma JR, Bermejo J, Bouza E, Fernández MA, Gonzalez-Ramallo V, Marín M, Muñoz P, Pedromingo M, Roda J, Rodríguez-Créixems M, Solis J, Almirante B, Fernandez-Hidalgo N, Tornos P, de Alarcón A, Parra R, Alestig E, Johansson M, Olaison L, Snygg-Martin U, Pachirat O, Pachirat P, Pussadhamma B, Senthong V, Casey A, Elliott T, Lambert P, Watkin R, Eyton C, Klein JL, Bradley S, Kauffman C, Bedimo R, Chu VH, Corey G, Crowley AL, Douglas P, Drew L, Fowler VG, Holland T, Lalani T, Mudrick D, Samad Z, Sexton D, Stryjewski M, Wang A, Woods CW, Lerakis S, Cantey R, Steed L, Wray D, Dickerman SA, Bonilla H, DiPersio J, Salstrom SJ, Baddley J, Patel M, Peterson G, Stancoven A, Afonso L, Kulman T, Levine D, Rybak M, Cabell CH, Baloch K, Chu VH, Corey G, Dixon CC, Fowler VG Jr, Harding T, Jones-Richmond M, Pappas P, Park LP, Redick T, Stafford J, Anstrom K, Athan E, Bayer AS, Cabell CH, Chu VH, Corey G, Fowler VG Jr, Bruno H, Karchmer AW, Miró JM, Murdoch DR, Sexton DJ, Wang A, Bayer rS, Cabell CH, Chu V, Corey G, Durack DT, Phil D, Eykyn S, Fowler VG Jr, Bruno H, Miró JM, Moreillon P, Olaison L, Raoult D, Rubinstein E, Sexton DJ.
PloS one.PLoS One.2013 May 17;8(5):e63181. doi: 10.1371/journal.pone.0063181. Print 2013.
The HACEK organisms (Haemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens, and Kingella species) are rare causes of infective endocarditis (IE). The objective of this study is to describe the clinical characteristics and outcomes of patients with HACEK endocardi
PMID 23690995

Japanese Journal

Rapid identification of Cardiobacterium hominis by MALDI-TOF mass spectrometry during infective endocarditis

Wallet Frederic,Loiez Caroline,Decoene Christophe [他]
Japanese Journal of Infectious Diseases 64(4), 327-329, 2011-07-00
NAID 40018924984

Infective endocarditis in a child caused by Cardiobacterium hominis after right ventricular outflow tract reconstruction using an expanded tetrafluoroethylene conduit

MAEKAWA Yoshiyuki,SAKAMOTO Takahiko,UMEZU Kentaroh,OHASHI Noburoh,HARADA Yorikazu
General thoracic and cardiovascular surgery 59(6), 429-432, 2011-06-10
NAID 10030256227

Related Pictures

★リンクテーブル★

リンク元	「HACEK」
関連記事	「Cardiobacterium」「hominis」

「HACEK」

Cardiobacterium hominis
	Cardiobacterium hominis on blood agar plate
Scientific classification
Kingdom:	Bacteria
Phylum:	Proteobacteria
Class:	Gammaproteobacteria
Order:	Cardiobacteriales
Family:	Cardiobacteriaceae
Genus:	Cardiobacterium
Species:	hominis

　　[★]

関: 感染性心内膜炎

「Cardiobacterium」

　　[★]

カルジオバクテリウム、カルジオバクテリウム属、Cardiobacterium属

関: Cardiobacteriaceae

「hominis」

　　[★]

Mycoplasma hominis、Blastocystis hominis

[pmid16955250-1] Malani AN, Aronoff DM, Bradley SF, Kauffman CA (September 2006). "Cardiobacterium hominis endocarditis: Two cases and a review of the literature". European Journal of Clinical Microbiology & Infectious Diseases 25 (9): 587–95. doi:10.1007/s10096-006-0189-9. PMC 2276845. PMID 16955250. Retrieved 2010-03-15.

[Savage-2] Savage DD, Kagan RL, Young NA, Horvath AE (January 1977). "Cardiobacterium hominis endocarditis: description of two patients and characterization of the organism". Journal of Clinical Microbiology 5 (1): 75–80. PMC 274535. PMID 833269. Retrieved 2010-03-15.

[Wilson-3] Wilson WR, Karchmer AW, Dajani AS, et al. (December 1995). "Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association". JAMA 274 (21): 1706–13. doi:10.1001/jama.274.21.1706. PMID 7474277. |accessdate= requires |url= (help)

[pmid10790145-4] Lu PL, Hsueh PR, Hung CC, Teng LJ, Jang TN, Luh KT (May 2000). "Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis". Journal of Clinical Microbiology 38 (5): 2015–7. PMC 86656. PMID 10790145. Retrieved 2010-03-15.

[isbn0-323-05470-6-5] Michael A. Pfaller; Murray, Patrick R.; Rosenthal, Ken S. (2009). Medical microbiology. Philadelphia: Mosby / Elsevier. p. 374. ISBN 0-323-05470-6.

匿名

検索

案内

案内

Cardiobacterium hominis